Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway.
Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway.
复制标题
Interleukin-17D 通过 p38 MAPK 信号通路诱导肿瘤相关巨噬细胞浸润,促进肺癌进展
DOI:
10.18632/aging.204208
复制
发表时间:
2022-08-05
期刊:
影响因子:
5.2
通讯作者:
Du, Wei
中科院分区:
文献类型:
--
作者:
Lin, Zhenzhen;Huang, Qiumin;Liu, Junrong;Wang, Hao;Zhang, Xuexi;Zhu, Zhiyan;Zhang, Wei;Wei, Yiliang;Liu, Zhe;Du, Wei
Cancer immunoediting is defined as the integration of the immune system’s dual host-protective and tumor-promoting roles, including three phases: elimination, equilibrium, and escape. Immune selective pressure causes tumor cells to lose major histocompatibility complex expression or acquire immunosuppressive gene expression, which promotes tumor immune evasion and tumor progression. Interleukin-17D (IL-17D), a member of the IL-17 family of cytokines, plays an important role in the host defense against infection and inflammation. However, the role of IL-17D in the progression of lung cancer remains unclear. In this study, we found that IL-17D was highly expressed in human lung cancer, and increased IL-17D expression was associated with tumor stage and short overall survival. IL-17D overexpression significantly promoted tumor growth in subcutaneous xenograft mouse models but only slightly affected cell proliferation in vitro. Using flow cytometry, we found that IL-17D overexpression enhances the recruitment of tumor-associated macrophages to the tumor microenvironment. Based on the expression profile of IL17D–overexpressing A549 cells, we found that IL-17D increased the expression levels of macrophage polarization– and recruitment–related genes through the MAPK signaling pathway. Moreover, inhibition of the p38 pathway blocked macrophage infiltration induced by IL-17D. These results suggest that IL-17D regulates the tumor immune microenvironment via the p38 MAPK signaling pathway, highlighting IL-17D as a potential therapeutic target for lung cancer.
登录
查看更多内容
影响因子:
7.3
作者:
Lee, Younghee;Clinton, Jelita;Chang, Seon Hee
通讯作者:
Chang, Seon Hee
影响因子:
16.6
作者:
Niederst, Matthew J.;Sequist, Lecia V.;Poirier, John T.;Mermel, Craig H.;Lockerman, Elizabeth L.;Garcia, Angel R.;Katayama, Ryohei;Costa, Carlotta;Ross, Kenneth N.;Moran, Teresa;Howe, Emily;Fulton, Linnea E.;Mulvey, Hillary E.;Bernardo, Lindsay A.;Mohamoud, Farhiya;Miyoshi, Norikatsu;VanderLaan, Paul A.;Costa, Daniel B.;Jaenne, Pasi A.;Borger, Darrell R.;Ramaswamy, Sridhar;Shioda, Toshi;Iafrate, Anthony J.;Getz, Gad;Rudin, Charles M.;Mino-Kenudson, Mari;Engelman, Jeffrey A.
通讯作者:
Engelman, Jeffrey A.
影响因子:
4.6
作者:
Li Q;Liu L;Zhang Q;Liu S;Ge D;You Z
通讯作者:
You Z
影响因子:
15.3
作者:
Chen, Xing;Cai, Gang;Li, Xiaoxia
通讯作者:
Li, Xiaoxia
影响因子:
4.7
作者:
HEIL, J;REIFFERSCHEID, G
通讯作者:
REIFFERSCHEID, G